[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Hadjichristodoulou et al., 1994 - Google Patents

Tolerance of the human brucellosis vaccine and the intradermal reaction test for brucellosis

Hadjichristodoulou et al., 1994

Document ID
3760985439452770986
Author
Hadjichristodoulou C
Voulgaris P
Toulieres L
Babalis T
Manetas S
Goutziana G
Kastritis I
Tselentis I
Publication year
Publication venue
European Journal of Clinical Microbiology and Infectious Diseases

External Links

Snippet

The aim of the present study was to determine the tolerance and efficacy of human brucellosis vaccine as well as the tolerance and sensitivity of the intradermal reaction test for brucellosis. A total of 1,121 subjects initially consented to participate in the study. Following …
Continue reading at link.springer.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions

Similar Documents

Publication Publication Date Title
Marmion et al. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs
España et al. Q fever (Coxiella burnetii)
Schaefer Serologic identification and classification of the atypical mycobacteria by their agglutination
Collins Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome
Koets et al. Mycobacterial 70 kD heat-shock protein is an effective subunit vaccine against bovine paratuberculosis
Wedlock et al. Control of Mycobacterium bovis infections and the risk to human populations
Buddle et al. Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis
Nakamura et al. MPB64 mycobacterial antigen: a new skin-test reagent through patch method for rapid diagnosis of active tuberculosis
Buddle et al. Low oral BCG doses fail to protect cattle against an experimental challenge with Mycobacterium bovis
Hoft et al. Clinical reactogenicity of intradermal bacille Calmette-Guerin vaccination
Blaser et al. Serologic study of two clusters of infection due to Campylobacter jejuni
Hadjichristodoulou et al. Tolerance of the human brucellosis vaccine and the intradermal reaction test for brucellosis
US20100278742A1 (en) Methods and compositions for detection and diagnosis of infectious diseases
Parlane et al. Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection
Koskela et al. Cell-mediated immunity against Francisella tularensis after natural infection
Shlyakhov et al. Anthrax post-vaccinal cell-mediated immunity in humans: kinetics pattern
Basybekov et al. Diagnostics of tuberculosis and differentiation of nonspecific tuberculin reactions in animals
Silber Rocky Mountain spotted fever
Gombosova et al. Immunotherapeutic effect of the lactobacillus vaccine, Solco Trichovac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis.
Agulló-Ros et al. Effect of heat-inactivated Mycobacterium avium subspecies paratuberculosis (MAP) vaccine on the lesions and immunopathology developed in target tissues of naturally MAP-infected goats
Von Reyn et al. Immunization of healthy adult subjects in the United States with inactivated Mycobacterium vaccae administered in a three-dose series
Rothstein et al. An acellular pertussis vaccine in healthy adults: safety and immunogenicity
Chappel et al. Serological titres to Leptospira fainei serovar hurstbridge in human sera in Australia
Salazar-Vergara et al. Tuberculosis infection and disease in children living in households of Filipino patients with tuberculosis: a preliminary report
Stabel et al. Comparative cellular immune responses in calves after infection with Mycobacterium avium subsp. paratuberculosis, M. avium subsp. avium, M. kansasii and M. bovis